The Gross Margin of Supernus Pharmaceuticals Inc (SUPN) is 89.57%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 89.57% |
| 2023-12-31 | 86.21% |
| 2022-12-31 | 86.93% |
| 2021-12-31 | 87.05% |
| 2020-12-31 | 89.91% |
| 2019-12-31 | 95.75% |
| 2018-12-31 | 96.23% |
| 2017-12-31 | 94.97% |
| 2016-12-31 | 94.42% |
| 2015-12-31 | 94.31% |